SEEMA BAG

Employment

• MapLight Therapeutics Inc. Principal Scientist
  2025 - Present
• Relay Therapeutics (United States) Senior Manager
  2022 - 2025

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (2)

• From Chiral Separation to Asymmetric Synthesis: Route Scouting and Early Process Development of a Chiral Tetrahydrofuran–Pyrazolamine Intermediate of CDK2 Inhibitor RLY-2139
  Organic Process Research & Development 2026 DOI: 10.1021/acs.oprd.5c00354
  +Save
• Process Development and Scale-Up of RLY-2139: A Selective CDK2 Inhibitor Targeting ER+/HER2– Breast Cancer
  Organic Process Research & Development 2026 DOI: 10.1021/acs.oprd.5c00342
  +Save